Life Sciences Law & Industry Report covered by BNA & Carswell.The Bureau of National Affairs BNA (The Bureau of National Affairs, Inc.) is a Washington, D.C.-based publisher of news and information on legislation, regulations, and court decisions for professionals in business and government. It is the oldest wholly employee-owned company in the United States. (BNA BNA Bureau of National Affairs, Inc. BNA Birds of North America BNA block numbering area (US Census) BNA British North America BNA Banco Nacional de Angola (National Bank of Angola) ; Washington, D C.) has begun the publication of "Life Sciences Law & Industry Report," a notification service that covers news and developments in the life sciences industry. Produced biweekly, it includes updates on current regulatory, legislative and legal issues. An annual subscription costs $.... Targeted to lawyers, business executives, regulators, directors of research and institutions, the title defines the life sciences industry as encompassing those individuals and entities that use advanced and emerging technologies to develop solutions that enhance human health and combat diseases. In that regard, it covers relevant federal, state and major international legislation, regulations, policies, and standards concerning the life sciences industry, from "biotechnology to patents to counterterrorism coun·ter·ter·ror adj. Intended to prevent or counteract terrorism: counterterror measures; counterterror weapons. n. Action or strategy intended to counteract or suppress terrorism. ," BNA said. It also includes information on newly issued court and administrative decisions affecting the life sciences, as well as current government enforcement activity, pending litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , settlements, Congressional hearings Congressional hearings are the principal formal method by which committees collect and analyze information in the early stages of legislative policymaking. Whether confirmation hearings — a procedure unique to the Senate — legislative, oversight, investigative, or a , bills and amendments, and commentary from practicing attorneys and government regulators. Major topics covered include: antitrust, information technology, government contracting, intellectual property, bioinformatics, biotechnology, drug delivery, nanotechnology, joint ventures, licensing agreements, patents, venture capital, pharmaceuticals, securities, taxation, stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young , sales and marketing, genomic medicine genomic medicine Molecular medicine The application of molecular methods to clinical medicine; MM encompasses diagnostic methods–eg, Southern, Western, and Northern blot hybridizations, DNA signal amplification by PCR, and use of agents produced by , FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. , and emerging technologies. Editorial also examines government and private efforts to encourage research and fund supporting structure. Also, Carswell (Toronto, ON) has begun the publication of "Life Sciences Law in Canada," a two-volume, loose-leaf subscription service that covers the protection of intellectual property associated with medicines, medical devices and natural health products. An annual subscription costs C$185. The service examines all legislation and regulations applicable to companies conducting business in Canada in the life sciences, including large pharmaceutical firms and small independent companies, and covers regulatory requirements affecting the marketing of drugs, medical devices and natural health products in Canada, including the Patented Medicines (Notice of Compliance) Regulations. It discusses the patent, trademark and copyright laws available to protect such products, such as biotechnological innovations, and the enforcement mechanisms for those rights. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion